Trial Profile
Multinational, Randomized, Double-Blind, Double-Dummy, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 25mg/kg od Versus 5 Days Azithromycin 10 mg/kg od Followed by 5 mg/kg od for 4 Days, in Children With Acute Otitis Media.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Telithromycin (Primary) ; Azithromycin
- Indications Bacterial infections; Otitis media
- Focus Therapeutic Use
- Acronyms TELICOM
- Sponsors Sanofi
- 08 Apr 2009 Planned end date (Jul 2006) added as reported by ClinicalTrials.gov.
- 08 Apr 2009 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 03 Aug 2007 Status changed from completed to suspended